[{"address1": "12730 High Bluff Drive", "address2": "Suite 400", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 500 8800", "website": "https://kuraoncology.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. Its lead product candidate includes ziftomenib, a selective investigational inhibitor of the menin-KMT2A interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; tipifarnib, an orally bioavailable farnesyl transferase inhibitor combination with alpelisib for patients with PIK3CA-dependent HNSCC; and KO-2806, a selective investigational FTI for the treatment of solid tumors. It has a clinical collaboration with Novartis Pharma AG to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression and/or PIK3CA mutation and/or amplification; strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize its oral menin inhibitor for the treatment of patients with acute myeloid leukemia (AML) and other hematologic malignancies; and a clinical collaboration with Mirati Therapeutics, Inc. to evaluate the combination of KO-2806 and adagrasib, a KRASG12C inhibitor in patients with NSCLC. The company is headquartered in San Diego, California.", "fullTimeEmployees": 192, "companyOfficers": [{"maxAge": 1, "name": "Dr. Troy Edward Wilson J.D., Ph.D.", "age": 55, "title": "Chairman, CEO & President", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 1296258, "exercisedValue": 1234936, "unexercisedValue": 15624}, {"maxAge": 1, "name": "Ms. Kathleen  Ford", "age": 77, "title": "Chief Operating Officer", "yearBorn": 1947, "fiscalYear": 2024, "totalPay": 868935, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Teresa Brophy Bair Esq., J.D.", "age": 53, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 745021, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thomas  Doyle", "age": 53, "title": "Senior Vice President of Finance & Accounting", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Francis J. Burrows Ph.D.", "age": 62, "title": "Chief Scientific Officer", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Roger  Bakale Ph.D.", "title": "Senior Vice President of Manufacturing & Supply Chain", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Maureen  Clancy M.B.A.", "title": "VP and Global Head of Program Leadership & Project Management", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mollie  Leoni M.D.", "age": 46, "title": "Chief Medical Officer", "yearBorn": 1978, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian T. Powl M.B.A., M.S.", "age": 50, "title": "Chief Commercial Officer", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 7, "compensationRisk": 6, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.43, "open": 6.3, "dayLow": 6.14, "dayHigh": 6.466, "regularMarketPreviousClose": 6.43, "regularMarketOpen": 6.3, "regularMarketDayLow": 6.14, "regularMarketDayHigh": 6.466, "payoutRatio": 0.0, "beta": 0.824, "forwardPE": -2.4082396, "volume": 984566, "regularMarketVolume": 984566, "averageVolume": 1493441, "averageVolume10days": 1770300, "averageDailyVolume10Day": 1770300, "bid": 4.61, "ask": 7.87, "bidSize": 2, "askSize": 2, "marketCap": 519399968, "fiftyTwoWeekLow": 5.41, "fiftyTwoWeekHigh": 23.48, "priceToSalesTrailing12Months": 9.639403, "fiftyDayAverage": 7.0251, "twoHundredDayAverage": 13.35915, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -191546608, "profitMargins": 0.0, "floatShares": 59774822, "sharesOutstanding": 80777600, "sharesShort": 8677940, "sharesShortPriorMonth": 9022023, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.1074, "heldPercentInsiders": 0.0117, "heldPercentInstitutions": 1.02272, "shortRatio": 5.87, "shortPercentOfFloat": 0.107700005, "impliedSharesOutstanding": 80777600, "bookValue": 5.288, "priceToBook": 1.2159606, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -173983008, "trailingEps": -2.02, "forwardEps": -2.67, "enterpriseToRevenue": -3.555, "enterpriseToEbitda": 0.996, "52WeekChange": -0.6794616, "SandP52WeekChange": 0.07995045, "quoteType": "EQUITY", "currentPrice": 6.43, "targetHighPrice": 40.0, "targetLowPrice": 10.0, "targetMeanPrice": 28.0, "targetMedianPrice": 28.5, "recommendationKey": "none", "numberOfAnalystOpinions": 12, "totalCash": 727395008, "totalCashPerShare": 9.007, "ebitda": -192347008, "totalDebt": 16594000, "quickRatio": 9.319, "currentRatio": 9.463, "totalRevenue": 53883000, "debtToEquity": 4.012, "revenuePerShare": 0.625, "returnOnAssets": -0.19973, "returnOnEquity": -0.4291, "grossProfits": -101464000, "freeCashflow": -55928752, "operatingCashflow": 134316992, "grossMargins": -1.88304, "ebitdaMargins": 0.0, "operatingMargins": -0.41674, "financialCurrency": "USD", "symbol": "KURA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "epsTrailingTwelveMonths": -2.02, "epsForward": -2.67, "epsCurrentYear": -2.19451, "priceEpsCurrentYear": -2.930039, "fiftyDayAverageChange": -0.5951004, "fiftyDayAverageChangePercent": -0.08471059, "twoHundredDayAverageChange": -6.92915, "twoHundredDayAverageChangePercent": -0.51868194, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "shortName": "Kura Oncology, Inc.", "longName": "Kura Oncology, Inc.", "marketState": "CLOSED", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1442410200000, "postMarketChangePercent": 0.0, "postMarketPrice": 6.43, "postMarketChange": 0.0, "regularMarketChange": 0.0, "regularMarketDayRange": "6.14 - 6.466", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1493441, "fiftyTwoWeekLowChange": 1.02, "fiftyTwoWeekLowChangePercent": 0.18853974, "fiftyTwoWeekRange": "5.41 - 23.48", "fiftyTwoWeekHighChange": -17.05, "fiftyTwoWeekHighChangePercent": -0.7261499, "fiftyTwoWeekChangePercent": -67.94616, "earningsTimestamp": 1746129600, "earningsTimestampStart": 1746129600, "earningsTimestampEnd": 1746129600, "earningsCallTimestampStart": 1746131400, "earningsCallTimestampEnd": 1746131400, "isEarningsDateEstimate": false, "corporateActions": [], "postMarketTime": 1745612835, "regularMarketTime": 1745611202, "exchange": "NMS", "messageBoardId": "finmb_282774456", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 6.43, "displayName": "Kura Oncology", "trailingPegRatio": null, "__fetch_time": "2025-04-26"}]